Home / Reuters changes the odds in race for Russell

Reuters changes the odds in race for Russell

News wire service Reuters has put the Chinese state-owned conglomerate CITIC Group as the frontrunner in a three-horse race to buy Russell Investments from London Stock Exchange. Reuters last month had Towers Watson as the most likely acquirer.
Reuters reported last week that CITIC was in negotiations with LSE for a deal reputedly worth about US$1.8 billion. Formal bids closed last month, with speculation putting the remaining three bidders as Towers Watson, CITIC and Chinese games manufacturer Shanda Group.
LSE bought the Russell group from Northwestern Mutual last year for US$2.7 billion, with its index business being the main area of interest. The multi-manager and investment consulting businesses were then put up for sale this year, with advice from JP Morgan Chase. Initially, it was thought that a private equity firm or a European-based manager was the most likely buyer but none materialised.
This month Towers Watson announced a merger with Willis Group, which some say may complicate a bid for Russell, although others say it gives Towers Watson more firepower to complete a deal. The Willis merger will not be completed until late this year.

Investor Strategy News




  • Print Article

    Related
    ‘Bubble thinking’: Howard Marks on market blow-ups

    Higher starting valuations usually lead to lower returns, but the most important part of a bubble is “highly skewed psychology” – and investors remain anchored to sanity.

    David Chaplin | 10th Jan 2025 | More
    ‘Martian real estate’ and bittersweet farewells: ISN’s top 10 stories of 2024

    This year’s top 10 stories included a peek into AustralianSuper’s international equities build out in London, AMP’s move to slash employee benefits, and plenty of hard-hitting analysis of the issues that matter in institutional investment. But the real story is how readers helped shape all of that coverage.

    Lachlan Maddock | 18th Dec 2024 | More
    ‘Nothing will stop me’: Stuart Place rides 15,451 km for son’s rare disease

    Orbis’ Stuart Place is riding from Melbourne to the Moon and Back to fund a treatment for the “monster of a disease” that his youngest son was born with. The investment industry is rallying behind him.

    Lachlan Maddock | 18th Dec 2024 | More
    Popular